104 related articles for article (PubMed ID: 11480390)
1. Tartrate-resistant acid phosphatase as a serum marker of bone resorption.
Halleen JM; Ranta R
Am Clin Lab; 2001 Jul; 20(6):29-30. PubMed ID: 11480390
[No Abstract] [Full Text] [Related]
2. [Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker].
Nowak Z; Konieczna M; Saracyn M; Wańkowicz Z
Pol Merkur Lekarski; 2008 Apr; 24(142):351-4. PubMed ID: 18634372
[TBL] [Abstract][Full Text] [Related]
3. Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption.
Halleen JM; Alatalo SL; Janckila AJ; Woitge HW; Seibel MJ; Väänänen HK
Clin Chem; 2001 Mar; 47(3):597-600. PubMed ID: 11238321
[No Abstract] [Full Text] [Related]
4. [Tartrate resistant acid phosphatase].
Yoh K
Nihon Rinsho; 2004 Feb; 62 Suppl 2():349-53. PubMed ID: 15035150
[No Abstract] [Full Text] [Related]
5. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
Halleen JM
Anticancer Res; 2003; 23(2A):1027-9. PubMed ID: 12820342
[TBL] [Abstract][Full Text] [Related]
6. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK
Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477
[TBL] [Abstract][Full Text] [Related]
7. Increased tartrate-resistant acid phosphatase serum levels in ankylosing spondylitis and relationship with the inflammatory process.
Toussirot E; Dumoulin G; Saas P; Nguyen NU; Le Huédé G; Wendling D
Ann Rheum Dis; 2008 Mar; 67(3):430-1. PubMed ID: 18292108
[No Abstract] [Full Text] [Related]
8. [Tartrate resistant acid phosphatase].
Yoh K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():215-9. PubMed ID: 15658303
[No Abstract] [Full Text] [Related]
9. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption.
Halleen JM; Alatalo SL; Suominen H; Cheng S; Janckila AJ; Väänänen HK
J Bone Miner Res; 2000 Jul; 15(7):1337-45. PubMed ID: 10893682
[TBL] [Abstract][Full Text] [Related]
10. [TARTRAT-RESISTANT ACID PHOSPHATASE AS BONE'S RESORBTION MARKER IN PATIENTS WITH BONE METASTASES].
Dedkov AG; Boychuk SI; Stakhovsky EA; Kukushkina MN; Kovalchuk PA
Lik Sprava; 2015; (5-6):104-9. PubMed ID: 27089726
[TBL] [Abstract][Full Text] [Related]
11. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
[TBL] [Abstract][Full Text] [Related]
12. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
Hannon RA; Clowes JA; Eagleton AC; Al Hadari A; Eastell R; Blumsohn A
Bone; 2004 Jan; 34(1):187-94. PubMed ID: 14751577
[TBL] [Abstract][Full Text] [Related]
13. [Development for the determination of band 5b tartrate-resistant acid phosphatase activity in serum].
Uchida K; Nakanishi M; Yoh K
Rinsho Byori; 2001 Jan; 49(1):51-5. PubMed ID: 11215484
[TBL] [Abstract][Full Text] [Related]
14. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis].
Nowak Z; Konieczna M; Wańkowicz Z
Pol Merkur Lekarski; 2004 Aug; 17(98):138-41. PubMed ID: 15603322
[TBL] [Abstract][Full Text] [Related]
15. Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases.
Tauchert S; di Liberto A; Cordes T; Thill M; Salehin D; Friedrich M
Clin Exp Obstet Gynecol; 2009; 36(4):219-25. PubMed ID: 20101852
[TBL] [Abstract][Full Text] [Related]
16. Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b.
Ohashi T; Igarashi Y; Mochizuki Y; Miura T; Inaba N; Katayama K; Tomonaga T; Nomura F
Clin Chim Acta; 2007 Feb; 376(1-2):205-12. PubMed ID: 17045980
[TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
López Gavilanes E; González Parra E; de la Piedra C; Caramelo C; Rapado A
Miner Electrolyte Metab; 1994; 20(5):259-64. PubMed ID: 7700213
[TBL] [Abstract][Full Text] [Related]
18. High bilirubin levels interfere with serum tartrate-resistant acid phosphatase determination: relevance as a marker of bone resorption in jaundiced patients.
Alvarez L; Peris P; Bedini JL; Parés A; Monegal A; Guañabens N; Mas E; Aibar C; Ballesta AM
Calcif Tissue Int; 1999 Apr; 64(4):301-3. PubMed ID: 10089222
[TBL] [Abstract][Full Text] [Related]
19. Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism.
Lu KC; Tseng CF; Wu CC; Yeung LK; Chen JS; Chao TY; Janckila AJ; Yam LT; Chu P
Blood Purif; 2006; 24(5-6):423-30. PubMed ID: 16888370
[TBL] [Abstract][Full Text] [Related]
20. Tartrate-resistant acid phosphatase (TRACP 5b): a biomarker of bone resorption rate in support of drug development: modification, validation and application of the BoneTRAP kit assay.
Wu Y; Lee JW; Uy L; Abosaleem B; Gunn H; Ma M; DeSilva B
J Pharm Biomed Anal; 2009 Jul; 49(5):1203-12. PubMed ID: 19356879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]